Previous Article | Next Article ![]()
Molecular and Cellular Biology, December 2000, p. 8983-8995, Vol. 20, No. 23
Molecular Medicine Division, Oregon Health
Sciences University, Portland, Oregon 97201-3098
Received 6 April 2000/Returned for modification 24 May
2000/Accepted 28 August 2000
Polypeptide growth factors activate specific transmembrane
receptors, leading to the induction of multiple intracellular signal transduction pathways which control cell function and fate. Recent studies have shown that growth factors promote cell survival by stimulating the serine-threonine protein kinase Akt, which appears to
function primarily as an antiapoptotic agent by inactivating death-promoting molecules. We previously established C2 muscle cell
lines lacking endogenous expression of insulin-like growth factor II
(IGF-II). These cells underwent apoptotic death in low-serum differentiation medium but could be maintained as viable myoblasts by
IGF analogues that activated the IGF-I receptor or by unrelated growth
factors such as platelet-derived growth factor BB (PDGF-BB). Here we
show that IGF-I promotes muscle cell survival through Akt-mediated
induction of the cyclin-dependent kinase inhibitor p21. Treatment of
myoblasts with IGF-I or transfection with an inducible Akt maintained
muscle cell survival and enhanced production of p21, and ectopic
expression of p21 was able to sustain viability in the absence of
growth factors. Blocking of p21 protein accumulation through a specific
p21 antisense cDNA prevented survival regulated by IGF-I or Akt but did
not block muscle cell viability mediated by PDGF-BB. Our results define
Akt as an intermediate and p21 as a critical effector of an
IGF-controlled myoblast survival pathway that is active during early
myogenic differentiation and show that growth factors are able to
maintain cell viability by inducing expression of pro-survival molecules.
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Insulin-Like Growth Factor-Mediated Muscle Cell
Survival: Central Roles for Akt and Cyclin-Dependent Kinase
Inhibitor p21
*
Corresponding author. Mailing address: Oregon Health
Sciences University, Molecular Medicine Division, 3181 S.W. Sam Jackson Park Rd., Mail code: NRC3, Portland, OR 97201-3098. Phone: (503) 494-0536. Fax: (503) 494-7368. E-mail: rotweinp{at}ohsu.edu.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|